| Heterozygous activating mutation in RAC2 causes infantile-onset combined immunodeficiency with susceptibility to viral infections SO Sharapova, E Haapaniemi, IS Sakovich, LV Kostyuchenko, A Donko, ... Clinical Immunology 205, 1-5, 2019 | 33 | 2019 |
| Multi-antigen DNA vaccine delivered by polyethylenimine and Salmonella enterica in neuroblastoma mouse model MV Stegantseva, VA Shinkevich, EM Tumar, AN Meleshko Cancer Immunology, Immunotherapy 69 (12), 2613-2622, 2020 | 22 | 2020 |
| Conjugation of new DNA vaccine with polyethylenimine induces cellular immune response and tumor regression in neuroblastoma mouse model MV Stegantseva, VA Shinkevich, EM Tumar, AN Meleshko Experimental Oncology 42 (2), 120-125, 2020 | 7 | 2020 |
| Method of quantitative assay of circular molecules of T-and b-cell receptor, TREC and KREC, in peripheral blood by real-time PCR MV Stegantseva, IE Guryanova, IS Sakovich, EA Polyakova, ... Eurasian J Oncol 5 (3), 449-56, 2017 | 5 | 2017 |
| Design and immunogenicity of SARS-coV-2 DNA vaccine encoding RBD-PVXCP fusion protein D Dormeshkin, M Katsin, M Stegantseva, S Golenchenko, M Shapira, ... Vaccines 11 (6), 1014, 2023 | 4 | 2023 |
| Monitoring of post-transplant naïve lymphocytes reconstitution in PID patients using TREC and KREC quantification E Polyakova, M Stegantseva, M Belevtsev JOURNAL OF CLINICAL IMMUNOLOGY 41 (SUPPL 1), S111-S111, 2021 | 2 | 2021 |
| Nijmegen breakage syndrome in two half sibs with peripheral T-cell lymphoma and cortical T-cell acute lymphoid leukemia SO Sharapova, EI Golovataya, EV Shepelevich, YE Mareika, ... Central European Journal of Immunology 45 (4), 507-510, 2020 | 2 | 2020 |
| Clinical and biological features of acute myeloid leukemia with MLL gene rearrangements in children and results of therapy according to protocols AML-MM-2000/2006 in the … YA Barovskaya, MV Stegantseva, OV Aleinikova Oncohematology 13 (4), 8-16, 2019 | 2 | 2019 |
| Brentuximab Vedotin Monotherapy and Combined with Low Dose Donor Lymphocyte Infusion to Control Minimal Residual Disease and Sustain Clinical Remission in a Child with Relapsed … AS Fedorova, MV Stegantseva, NV Minakovskaya, OV Aleinikova Journal of Cancer Therapy 8 (08), 683, 2017 | 2 | 2017 |
| Anticancer DNA vaccination: principle and Perspectives of the method MV Stegantseva, AN Meleshko Meditsinskaya Immunologiya 19 (2), 145, 2017 | 2 | 2017 |
| Polyethylenimine increases the immunogenicity of DNA-vaccine based on the thyrosine hydroxylase gene in the mouse model of neuroblastoma MV Stegantseva, VA Shinkevich, KP Vashkevich, TM Mikhaleuskaya, ... Proceedings of the National Academy of Sciences of Belarus, Medical series …, 2018 | 1 | 2018 |
| Diagnostic significance of TREC and KRE Cevaluation in case of primary immunodeficiencies E Polyakova, M Stegantseva, I Guryanova, S Sharapova, S Beresten, ... Clinical Immunology 250, 109519, 2023 | | 2023 |
| Evaluation of functional activity of thymus and bone marrow of newborns using the method of TREC and KREC quantitation E Polyakova, S Beresten, A Starovoitova, M Stegantseva, I Guryanova, ... Clinical Immunology 250, 109520, 2023 | | 2023 |
| Opportunities for diagnostics of congenital and acquired immunological disorders in the Republic of Belarus V Kazak, M Stegantseva, I Guryanova, T Volodashchik, M Belevtsev, ... Clinical Immunology 250, 109521, 2023 | | 2023 |
| Dynamics of TREC and KREC for patients after therapy with anti-CD20 monoclonal antibodies E Polyakova, M Stegantseva, T Uglova, M Belevtsev Clinical Immunology 250, 109518, 2023 | | 2023 |
| Diagnosis of immune mechanism disorders in preterm infants using markers of T-and B-cell neogenesis (TREC and KREC) and subpopulations of T-and B-lymphocytes EA Polyakova, SA Beresten, MV Stegantseva, AS Starovoitova, ... Medical and Biological Problems of Life Activity, 93-98, 2022 | | 2022 |
| SAFETY AND TOXICITY OF NEW GENETICALLY MODIFIED ATTENUATED STRAIN OF SALMONELLA ENTERICA SEROVAR TYPHIMURIUM MV Stegantseva, VA Shinkevich, MA Derevyanko, IA Semenik, ... Молекулярная диагностика, 332-333, 2021 | | 2021 |
| DONOR CHIMERISM IN PATIENTS WITH PRIMARY IMMUNODEFICIENCY AFTER ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION VA Lavrinenko, YE Marejco, EY Berezovskaya, MV Stegantseva, ... Oncohematology 13 (2), 82-92, 2018 | | 2018 |
| EFFECT OF MOLECULAR GENETIC CHANGES ON THE PROGNOSIS IN CASE OF ACUTE MYELOID LEUKEMIA IN CHILDREN YA BAROUSKAYA, MV STEGANTSEVA, AM КUSTANOVICH, ... Proceedings of the National Academy of Sciences of Belarus, Medical series …, 2016 | | 2016 |
| The role and place of haemopoietic stem cell transplantation in treatment of acute myeloid leukemia in children. A Belarus experience YA Barovskaya, DV Prudnikov, NV Minakovskaya, MV Stegantseva, ... Pediatric Hematology/Oncology and Immunopathology 15 (4), 57-65, 2016 | | 2016 |
